LN-063116
14,15-Dehydro Budesonide , 90%+ , 131918-64-4
Update time: 2023-04-23
PRODUCT Properties
| Melting point: | 132-134°C |
| Boiling point: | 612.4±55.0 °C(Predicted) |
| Density | 1.30±0.1 g/cm3(Predicted) |
| storage temp. | -20°C Freezer |
| solubility | Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly) |
| pka | 12.82±0.10(Predicted) |
| form | Solid |
| color | White to Pale Yellow |
| Major Application | pharmaceutical (small molecule) |
| InChIKey | PMZXYZGZQZYDLA-BQKXZEBKSA-N |
| SMILES | O1[C@@]2([C@H](OC1CCC)C=C3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@@]54C)O)C)C(=O)CO |
Description and Uses
14,15-Dehydro Budesonide (Budesonide EP Impurity E) is a Budesonide (B689490) impurity.
Safety
| Symbol(GHS) | ![]() ![]() GHS08,GHS07 |
| Signal word | Danger |
| Hazard statements | H302-H317-H361d-H372-H412 |
| Precautionary statements | P202-P273-P280-P301+P312-P302+P352-P308+P313 |
| target organs | Adrenal gland |
| WGK Germany | WGK 3 |
| HS Code | 2937290000 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | Acute Tox. 4 Oral Aquatic Chronic 3 Repr. 2 Skin Sens. 1 STOT RE 1 Inhalation |




![16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers)](https://img.chemicalbook.com/CAS/GIF/1040085-99-1.gif)


